ImmunoGen (IMGN +3.7%) moves up after Cowen initiates coverage with an Outperform. The stock has...
ImmunoGen (IMGN +3.7%) moves up after Cowen initiates coverage with an Outperform. The stock has had a rough month, carving nearly 30% off its market cap following a disappointing FQ4 report on August 3rd. However, the stock appears to have stabilized, so from a valuation standpoint alone it appears there may be room for the shares to run.
From other sites
at CNBC.com (Dec 19, 2014)
at CNBC.com (Dec 2, 2014)
at CNBC.com (Sep 8, 2014)
at CNBC.com (Aug 14, 2014)
at CNBC.com (Jun 25, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs